tiprankstipranks
Viemed Healthcare US (VMD)
NASDAQ:VMD
US Market
VMD
Viemed Healthcare
RESEARCH TOOLSreports
Want to see VMD full AI Analyst Report?

Viemed Healthcare (VMD) Ratios

177 Followers

Viemed Healthcare Ratios

VMD's free cash flow for Q1 2026 was $0.56. For the 2026 fiscal year, VMD's free cash flow was decreased by $ and operating cash flow was $0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.22 1.18 1.42 1.19 2.11
Quick Ratio
 1.10 1.06 1.30 1.05 1.92
Cash Ratio
 0.24 0.33 0.47 0.40 0.90
Solvency Ratio
 0.86 0.61 0.84 0.78 1.10
Operating Cash Flow Ratio
 1.40 1.26 1.05 1.41 1.47
Short-Term Operating Cash Flow Coverage
 27.57 22.64 95.57 42.18 0.00
Net Current Asset Value
$ -1.75M$ -22.93M$ 9.11M$ -2.63M$ 19.79M
Leverage Ratios
Debt-to-Assets Ratio
 0.06 0.07 0.04 0.07 <0.01
Debt-to-Equity Ratio
 0.09 0.11 0.05 0.09 <0.01
Debt-to-Capital Ratio
 0.08 0.10 0.05 0.08 <0.01
Long-Term Debt-to-Capital Ratio
 0.05 0.07 0.03 0.05 0.00
Financial Leverage Ratio
 1.37 1.52 1.35 1.36 1.21
Debt Service Coverage Ratio
 13.83 13.00 31.69 21.74 111.92
Interest Coverage Ratio
 18.36 17.52 23.07 33.80 41.89
Debt to Market Cap
 0.03 0.05 0.01 0.02 0.00
Interest Debt Per Share
 0.36 0.44 0.20 0.28 0.02
Net Debt to EBITDA
 0.05 0.05 -0.25 -0.07 -0.65
Profitability Margins
Gross Profit Margin
57.32%57.52%59.40%61.63%60.99%
EBIT Margin
8.32%8.49%7.56%8.10%6.62%
EBITDA Margin
18.65%19.08%18.87%20.04%17.88%
Operating Profit Margin
8.38%7.66%7.98%7.83%5.94%
Pretax Profit Margin
7.71%8.05%7.21%7.86%6.48%
Net Profit Margin
5.20%5.53%5.02%5.60%4.48%
Continuous Operations Profit Margin
5.37%5.69%5.09%5.60%4.48%
Net Income Per EBT
67.39%68.61%69.67%71.18%69.21%
EBT Per EBIT
92.01%105.10%90.34%100.43%108.94%
Return on Assets (ROA)
7.55%6.95%6.36%6.61%5.32%
Return on Equity (ROE)
10.66%10.55%8.57%8.99%6.41%
Return on Capital Employed (ROCE)
15.33%11.91%12.81%11.67%8.40%
Return on Invested Capital (ROIC)
10.53%8.30%8.96%8.17%5.79%
Return on Tangible Assets
10.85%9.65%7.86%8.22%5.32%
Earnings Yield
4.02%5.17%3.62%3.40%2.13%
Efficiency Ratios
Receivables Turnover
 9.19 10.56 9.00 9.92 9.01
Payables Turnover
 14.26 15.66 17.11 9.48 11.04
Inventory Turnover
 23.60 22.75 21.08 15.17 15.15
Fixed Asset Turnover
 3.61 3.28 2.83 2.38 2.03
Asset Turnover
 1.45 1.26 1.27 1.18 1.19
Working Capital Turnover Ratio
 34.65 23.51 20.58 13.49 5.51
Cash Conversion Cycle
 29.59 27.29 36.53 22.34 31.54
Days of Sales Outstanding
 39.71 34.55 40.55 36.80 40.50
Days of Inventory Outstanding
 15.47 16.04 17.32 24.05 24.09
Days of Payables Outstanding
 25.59 23.31 21.33 38.51 33.05
Operating Cycle
 55.18 50.60 57.86 60.85 64.59
Cash Flow Ratios
Operating Cash Flow Per Share
 1.49 1.33 1.01 1.18 0.72
Free Cash Flow Per Share
 0.67 0.31 0.03 0.50 0.13
CapEx Per Share
 0.81 1.03 0.97 0.68 0.59
Free Cash Flow to Operating Cash Flow
 0.45 0.23 0.03 0.42 0.17
Dividend Paid and CapEx Coverage Ratio
 1.83 1.30 1.03 1.73 1.21
Capital Expenditure Coverage Ratio
 1.83 1.30 1.03 1.73 1.21
Operating Cash Flow Coverage Ratio
 4.59 3.26 5.69 4.38 39.98
Operating Cash Flow to Sales Ratio
 0.20 0.19 0.17 0.25 0.20
Free Cash Flow Yield
7.01%4.13%0.42%6.35%1.66%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 24.90 19.35 27.59 29.39 46.97
Price-to-Sales (P/S) Ratio
 1.29 1.07 1.39 1.65 2.10
Price-to-Book (P/B) Ratio
 2.58 2.04 2.37 2.64 3.01
Price-to-Free Cash Flow (P/FCF) Ratio
 14.27 24.22 235.82 15.75 60.25
Price-to-Operating Cash Flow Ratio
 6.49 5.57 7.95 6.66 10.53
Price-to-Earnings Growth (PEG) Ratio
 1.14 0.62 3.72 0.37 -1.35
Price-to-Fair Value
 2.58 2.04 2.37 2.64 3.01
Enterprise Value Multiple
 6.97 5.65 7.09 8.14 11.12
Enterprise Value
 372.63M 291.44M 300.14M 298.56M 276.01M
EV to EBITDA
 6.97 5.65 7.09 8.14 11.12
EV to Sales
 1.30 1.08 1.34 1.63 1.99
EV to Free Cash Flow
 14.38 24.43 227.72 15.62 56.91
EV to Operating Cash Flow
 6.52 5.61 7.68 6.60 9.95
Tangible Book Value Per Share
 2.23 2.14 2.57 2.18 2.51
Shareholders’ Equity Per Share
 3.74 3.64 3.39 2.97 2.51
Tax and Other Ratios
Effective Tax Rate
 0.30 0.29 0.29 0.29 0.31
Revenue Per Share
 7.46 6.95 5.79 4.77 3.59
Net Income Per Share
 0.39 0.38 0.29 0.27 0.16
Tax Burden
 0.67 0.69 0.70 0.71 0.69
Interest Burden
 0.93 0.95 0.95 0.97 0.98
Research & Development to Revenue
 <0.01 0.01 0.01 0.02 0.02
SG&A to Revenue
 0.47 0.48 0.50 0.51 0.53
Stock-Based Compensation to Revenue
 0.03 0.03 0.03 0.03 0.04
Income Quality
 3.77 3.48 3.43 4.41 4.46
Currency in USD